Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1155/week)
    • Manufacturing(555/week)
    • Technology(1085/week)
    • Energy(397/week)
    • Other Manufacturing(315/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Kazia Therapeutics Limited

Feb 20, 2025
Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease
Jan 10, 2025
Kazia Therapeutics Announces $2.0 Million Registered Direct Offering
Sep 23, 2024
Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium
Sep 12, 2024
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER
May 01, 2024
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
Jan 18, 2024
KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS
Sep 22, 2020
Kazia Enters Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma
Jun 22, 2020
Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs
Apr 07, 2020
Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study
Dec 11, 2019
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
Nov 25, 2019
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference
Sep 12, 2019
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway
May 20, 2019
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
May 08, 2019
New positive data from phase IIa trial in brain cancer patients
May 08, 2019
Kazia calls for greater awareness of the deadliest gynecological cancer in the US
Apr 01, 2019
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
Oct 29, 2018
Progress Update on GDC-0084 Program
Oct 22, 2018
Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer
Oct 10, 2018
Cantrixil Phase I Study Progresses To Next Stage
Jun 19, 2018
Kazia Releases Preliminary Cantrixil Phase I Data
  •  
  • Page 1
  • ››

Latest News

Jun 11, 2025

Sherritt Reports Shareholder Meeting Results, Board Appointments and Committee Updates

Jun 11, 2025

Voyager Announces Pricing of Initial Public Offering

Jun 11, 2025

H&P To Participate in J.P. Morgan 2025 Energy, Power and Renewables Conference

Jun 11, 2025

CACI President and CEO John Mengucci Named ‘Executive of the Year’ by ACG National Capital

Jun 11, 2025

Atlas Announces Timing of Second Quarter 2025 Earnings Release and Conference Call

Jun 11, 2025

Kaiser Aluminum Corporation Announces Appointment of Glenda J. Minor to its Board of Directors

Jun 11, 2025

The SEER Group Expands Northwest Presence With Acquisition of Oregon’s Associated Heating & Air...

Jun 11, 2025

Phillips 66 to Speak at the J.P. Morgan 2025 Energy, Power, Renewables & Mining Conference

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia